Molecular Characterisation of Trefoil Factor 1 from Cases of Canine Mammary Tumour
DOI:
https://doi.org/10.48165/ijvsbt.2026.22.06.01Keywords:
Canine mammary tumour, Gene cloning, Phylogenetic analysis, Trefoil Factor 1 (TFF1).Abstract
Canine mammary tumours (CMT) are among the most common neoplasms in female dogs and exhibit variable biological behaviour, necessitating the identification of reliable molecular biomarkers. Trefoil Factor 1 (TFF1) has been studied extensively in human cancers and has been found to be an important prognostic marker associated with tumour growth and progression. The present study was aimed to characterise TFF1 in canine mammary tumours tissues collected from clinical cases (n=10). Histopathological examination revealed diverse tumour patterns, including tubulopapillary carcinoma, carcinoma in situ, and stromal desmoplasia, indicating varying degrees of malignancy. Immunohistochemical analysis demonstrated variable cytoplasmic TFF1 expression in neoplastic epithelial cells, ranging from strong to weak immunoreactivity among different tumour subtypes, indicating heterogeneous protein expression within canine mammary tumours. At the molecular level, the canine TFF1 gene was successfully amplified, cloned and sequenced. Sequence analysis showed 100% nucleotide identity with the published canine TFF1 sequence, while phylogenetic analysis demonstrated a high degree of conservation among mammalian species, particularly within the Carnivora lineage, highlighting its evolutionary significance.
Downloads
References
Buache, E., Etique, N., Alpy, F., Stoll, I., Muckensturm, M., Reina-San-Martin, B., et al. (2011). Deficiency in trefoil factor 1 (TFF1) increases tumourigenicity of human breast cancer cells and mammary tumour development in TFF1-knockout mice. Oncogene, 30(29), 3261–3273.
Cassali, G. D., Jark, P. C., Gamba, C., Damasceno, K. A., Estrela-Lima, A., De Nardi, A. B., et al. (2020). Consensus regarding the diagnosis, prognosis and treatment of canine and feline mammary tumours—2019. Brazilian Journal of Veterinary Pathology, 13(3), 555–574.
Cavalcanti, M. F., & Cassali, G. D. (2006). Prognostic factors in the clinical and histopathological diagnosis of mammary tumours in female dogs: Review. Revista Clínica Veterinária, 61, 56–63.
Chinery, R., Williamson, J., & Poulsom, R. (1996). The gene encoding human intestinal trefoil factor (TFF3) is located on chromosome 21q22.3 clustered with other members of the trefoil peptide family. Genomics, 32(2), 281–284.
Clemente, M., Pérez-Alenza, M. D., Illera, J. C., & Peña, L. (2010). Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer. Veterinary Pathology, 47(2), 265–274.
De Nardi, A. B., Daleck, C. R., & Laufer-Amorim, R. (2007). Correlation of cyclooxygenase-2 with the prognosis of mammary carcinomas in female dogs. Acta Scientiae Veterinariae, 35, 619–627.
Dutra, A. P., Azevedo Junior, G. M., Schmitt, F. C., & Cassali, G. D. (2008). Assessment of cell proliferation and prognostic factors in canine mammary gland tumours. Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 60, 1403–1412.
Edgar, R. C. (2004). MUSCLE: Multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Research, 32(5), 1792–1797.
Fujimoto, J., Yasui, W., Tahara, H., Tahara, E., Kudo, Y., Yokozaki, H., et al. (2000). DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis. Cancer Letters, 149(1–2), 125–134.
Goldschmidt, M., Peña, L., Rasotto, R., & Zappulli, V. (2011). Classification and grading of canine mammary tumours. Veterinary Pathology, 48(1), 117–131.
Kumar, S., Stecher, G., & Tamura, K. (2016). MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Molecular Biology and Evolution, 33(7), 1870–1874.
Liu, D., Xiong, H., Ellis, A. E., Northrup, N. C., Rodriguez, C. O., O'Regan, R. M., et al. (2014). Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer. Cancer Research, 74(18), 5045–5056.
Mhawech-Fauceglia, P., Wang, D., Samrao, D., Liu, S., & Pejovic, T. (2013). Trefoil factor family 3 (TFF3) expression and its interaction with estrogen receptor (ER) in endometrial adenocarcinoma. Gynecologic Oncology, 130(1), 174–180.
Narad, A., Shukla, S., Sood, N. K., & Jatav, G. P. (2026). Application of immunohistochemistry in tumour classification: A comparative study of canine and human tissues. The Indian Journal of Veterinary Sciences and Biotechnology, 22(1), 26–31.
Pandey, V., Wu, Z. S., Zhang, M., Li, R., Zhang, J., Zhu, T., et al. (2014). Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma. Breast Cancer Research, 16, 429.
Park, W. S., Oh, R. R., Park, J. Y., Lee, J. H., Shin, M. S., Kim, H. S., et al. (2000). Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology, 119(3), 691–698.
Sánchez-Céspedes, R., Fernández-Martínez, M. D., Raya, A. I., Pineda, C., López, I., & Millán, Y. (2021). Vitamin D receptor (VDR) expression in different molecular subtypes of canine mammary carcinoma. BMC Veterinary Research, 17, 1–14.
Shang, Y. L., & Qian, Y. B. (2014). Clinical significance of expression of trefoil factor 3 in hepatocellular carcinoma. World Chinese Journal of Digestology, 22(8), 1141–1145.
Sorenmo, K., Rasotto, R., Zappulli, V., & Goldschmidt, M. H. (2011). Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms. Veterinary Pathology, 48(1), 85–97.
Wong, W. M., Poulsom, R., & Wright, N. A. (1999). Trefoil peptides. Gut, 44(6), 890–895.
Wright, N. A., Poulsom, R., Stamp, G., Van Noorden, S., Sarraf, C., Elia, G., et al. (1993). Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology, 104(1), 12–20.
Published
Issue
Section
License
Copyright (c) 2026 Indian Journal of Veterinary Sciences and Biotechnology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
